Back
CRISPR Therapeutics AG Stock Price Chart
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Buy
61
CRSP
CRISPR Therapeutics AG
Last Price:
48.75
Seasonality Move:
18.54%
7 Day Trial
ALL ACCESS PASS
$
7
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.32 | Sell |
| 20-day SMA: | 49.5 | Buy |
| 50-day SMA: | 47.73 | Buy |
| 200-day SMA: | 57.77 | Sell |
| 8-day EMA: | 50.93 | Sell |
| 20-day EMA: | 49.77 | Buy |
| 50-day EMA: | 49.08 | Buy |
| 200-day EMA: | 53.72 | Sell |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.12 | Buy |
| Relative Strength Index (14 RSI): | 51.22 | Buy |
| Chaikin Money Flow: | -1380018 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.76 - 51.12) | Buy |
| Bollinger Bands (100): | (45.94 - 54.52) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 49.79 while CRSP 8-day simple moving average is 51.32, which is a Sell signal.
- The stock price of CRSP is 49.79 while CRISPR Therapeutics AG 20-day SMA is 49.50, which makes it a Buy.
- CRISPR Therapeutics AG 50-day simple moving average is 47.73 while CRSP share price is 49.79, making it a Buy technically.
- CRSP stock price is 49.79 and CRISPR Therapeutics AG 200-day simple moving average is 57.77, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Buy
61
CRISPR Therapeutics AG (CRSP)
is a Buy
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a Buy
The current CRISPR Therapeutics AG [CRSP] share price is $49.79. The Score for CRSP is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
4.25B
Price in USD:
49.79
Share Volume:
1.85M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
91.10
52-Week Low:
43.42
Buy
61
CRISPR Therapeutics AG (CRSP)
is a Buy
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?
The CRISPR Therapeutics AG stock price is 49.79 USD today. -
Will CRSP stock go up or go down?
CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators -
Is CRISPR Therapeutics AG overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is not overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 49.79 while CRSP 8-day exponential moving average is 50.93, which is a Sell signal.
- The stock price of CRSP is 49.79 while CRISPR Therapeutics AG 20-day EMA is 49.77, which makes it a Buy.
- CRISPR Therapeutics AG 50-day exponential moving average is 49.08 while CRSP share price is 49.79, making it a Buy technically.
- CRSP stock price is 49.79 and CRISPR Therapeutics AG 200-day simple moving average is 53.72, creating a Sell signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.19 per share, and an increase next year of $0.13 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
- CRSP Moving Average Covergence Divergence (MACD) indicator is 1.12, suggesting CRISPR Therapeutics AG is a Buy
- CRISPR Therapeutics AG Relative Strength Index (RSI) is 51.22, which suggest CRISPR Therapeutics AG is overbought
- The Bollinger Bands (25) for CRISPR Therapeutics AG is (46.76 - 51.12), which suggest CRISPR Therapeutics AG is a Sell
- The Bollinger Bands (100) for CRISPR Therapeutics AG is (45.94 - 54.52), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.